{
  "DOI": "10.1007/s10689-017-0011-0",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-017-0011-0",
  "alternative-id": [
    "11"
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0001-7856-0057",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Dominguez-Valentin",
      "given": "Mev",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Nakken",
      "given": "Sigve",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tubeuf",
      "given": "Hélène",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Vodak",
      "given": "Daniel",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ekstrøm",
      "given": "Per Olaf",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Nissen",
      "given": "Anke M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Morak",
      "given": "Monika",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Holinski-Feder",
      "given": "Elke",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Martins",
      "given": "Alexandra",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Møller",
      "given": "Pål",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hovig",
      "given": "Eivind",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2017,
        6,
        12
      ]
    ],
    "date-time": "2017-06-12T10:09:09Z",
    "timestamp": 1497262149000
  },
  "deposited": {
    "date-parts": [
      [
        2020,
        5,
        18
      ]
    ],
    "date-time": "2020-05-18T00:06:59Z",
    "timestamp": 1589760419000
  },
  "funder": [
    {
      "name": "Radiumhospitalets Forskningsstifltelse (NO)"
    },
    {
      "DOI": "10.13039/501100006095",
      "doi-asserted-by": "publisher",
      "name": "Helse Sør-Øst RHF"
    },
    {
      "name": "French Association Recherche contre le cancer (ARC)"
    },
    {
      "DOI": "10.13039/501100014808",
      "doi-asserted-by": "crossref",
      "name": "Groupement des Entreprises Françaises dans la Lutte contre le Cancer"
    },
    {
      "DOI": "10.13039/501100003032",
      "doi-asserted-by": "crossref",
      "name": "Association Nationale de la Recherche et de la Technologie"
    },
    {
      "name": "OpenHealth Institute"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2023,
        11,
        22
      ]
    ],
    "date-time": "2023-11-22T09:43:46Z",
    "timestamp": 1700646226868
  },
  "is-referenced-by-count": 11,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2017,
        6,
        12
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2018,
          1
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "unspecified",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2017,
            6,
            12
          ]
        ],
        "date-time": "2017-06-12T00:00:00Z",
        "timestamp": 1497225600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-017-0011-0/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-017-0011-0.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-017-0011-0.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "141-153",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2017,
        6,
        12
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2017,
        6,
        12
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2018,
        1
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1200/JCO.2013.53.6607",
      "author": "AW Kurian",
      "doi-asserted-by": "publisher",
      "first-page": "2001",
      "issue": "19",
      "journal-title": "J Clin Oncol",
      "key": "11_CR1",
      "unstructured": "Kurian AW, Hare EE, Mills MA et al (2014) Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment. J Clin Oncol 32(19):2001–2009. doi:\n10.1200/JCO.2013.53.6607",
      "volume": "32",
      "year": "2014"
    },
    {
      "DOI": "10.1038/gim.2013.166",
      "author": "M Hegde",
      "doi-asserted-by": "publisher",
      "first-page": "101",
      "issue": "1",
      "journal-title": "Genet Med",
      "key": "11_CR2",
      "unstructured": "Hegde M, Ferber M, Mao R et al (2014) ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis). Genet Med 16(1):101–116. doi:\n10.1038/gim.2013.166",
      "volume": "16",
      "year": "2014"
    },
    {
      "DOI": "10.1038/gim.2015.30",
      "author": "S Richards",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "issue": "5",
      "journal-title": "Genet Med",
      "key": "11_CR3",
      "unstructured": "Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424. doi:\n10.1038/gim.2015.30",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1038/gim.2016.13",
      "author": "J Kleinberger",
      "doi-asserted-by": "publisher",
      "first-page": "1165",
      "issue": "11",
      "journal-title": "Genet Med",
      "key": "11_CR4",
      "unstructured": "Kleinberger J, Maloney KA, Pollin TI, Jeng LJ (2016) An openly available online tool for implementing the ACMG/AMP standards and guidelines for the interpretation of sequence variants. Genet Med 18(11):1165. doi:\n10.1038/gim.2016.13",
      "volume": "18",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.ajhg.2016.06.001",
      "author": "LM Amendola",
      "doi-asserted-by": "publisher",
      "first-page": "247",
      "issue": "1",
      "journal-title": "Am J Hum Genet",
      "key": "11_CR5",
      "unstructured": "Amendola LM, Jarvik GP, Leo MC et al (2016) Performance of ACMG-AMP variant-interpretation guidelines among nine laboratories in the clinical sequencing exploratory research consortium (vol 98, pg 1067, 2016). Am J Hum Genet 99(1):247. doi:\n10.1016/j.ajhg.2016.06.001",
      "volume": "99",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.ajhg.2016.02.024",
      "author": "KN Maxwell",
      "doi-asserted-by": "publisher",
      "first-page": "801",
      "issue": "5",
      "journal-title": "Am J Hum Genet",
      "key": "11_CR6",
      "unstructured": "Maxwell KN, Hart SN, Vijai J et al (2016) Evaluation of ACMG-guideline-based variant classification of cancer susceptibility and non-cancer-associated genes in families affected by breast cancer. Am J Hum Genet 98(5):801–817. doi:\n10.1016/j.ajhg.2016.02.024",
      "volume": "98",
      "year": "2016"
    },
    {
      "DOI": "10.1038/gim.2016.39",
      "author": "KS Park",
      "doi-asserted-by": "publisher",
      "first-page": "1250",
      "issue": "12",
      "journal-title": "Genet Med",
      "key": "11_CR7",
      "unstructured": "Park KS, Cho EY, Nam SJ, Ki CS, Kim JW (2016) Comparative analysis of BRCA1 and BRCA2 variants of uncertain significance in patients with breast cancer: a multifactorial probability-based model versus ACMG standards and guidelines for interpreting sequence variants. Genet Med 18(12):1250–1257. doi:\n10.1038/gim.2016.39",
      "volume": "18",
      "year": "2016"
    },
    {
      "DOI": "10.1002/ijc.28988",
      "author": "C Cybulski",
      "doi-asserted-by": "publisher",
      "first-page": "1756",
      "issue": "8",
      "journal-title": "Int J Cancer",
      "key": "11_CR8",
      "unstructured": "Cybulski C, Nazarali S, Narod SA (2014) Multiple primary cancers as a guide to heritability. Int J Cancer 135(8):1756–1763. doi:\n10.1002/ijc.28988",
      "volume": "135",
      "year": "2014"
    },
    {
      "DOI": "10.1001/jama.279.12.922",
      "author": "KE Malone",
      "doi-asserted-by": "publisher",
      "first-page": "922",
      "issue": "12",
      "journal-title": "Jama",
      "key": "11_CR9",
      "unstructured": "Malone KE, Daling JR, Thompson JD, O’Brien CA, Francisco LV, Ostrander EA (1998) BRCA1 mutations and breast cancer in the general population - Analyses in women before age 35 years and in women before age 45 years with first-degree family history. Jama 279(12):922–929 doi:\n10.1001/jama.279.12.922",
      "volume": "279",
      "year": "1998"
    },
    {
      "DOI": "10.1093/jnci/91.11.943",
      "author": "J Peto",
      "doi-asserted-by": "crossref",
      "first-page": "943",
      "issue": "11",
      "journal-title": "J Natl Cancer Inst",
      "key": "11_CR10",
      "unstructured": "Peto J, Collins N, Barfoot R et al (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91(11):943–949",
      "volume": "91",
      "year": "1999"
    },
    {
      "DOI": "10.1111/j.1399-0004.2007.00747.x",
      "author": "M Loizidou",
      "doi-asserted-by": "publisher",
      "first-page": "165",
      "issue": "2",
      "journal-title": "Clin Genet",
      "key": "11_CR11",
      "unstructured": "Loizidou M, Marcou Y, Anastasiadou V, Newbold R, Hadjisavvas A, Kyriacou K (2007) Contribution of BRCA1 and BRCA2 germline mutations to the incidence of early-onset breast cancer in Cyprus. Clin Genet 71(2):165–170. doi:\n10.1111/j.1399-0004.2007.00747.x",
      "volume": "71",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.ejca.2007.04.023",
      "author": "P Moller",
      "doi-asserted-by": "publisher",
      "first-page": "1713",
      "issue": "11",
      "journal-title": "Eur J Cancer",
      "key": "11_CR12",
      "unstructured": "Moller P, Hagen AI, Apold J et al (2007) Genetic epidemiology of BRCA mutations—family history detects less than 50% of the mutation carriers. Eur J Cancer 43(11):1713–1717. doi:\n10.1016/j.ejca.2007.04.023",
      "volume": "43",
      "year": "2007"
    },
    {
      "DOI": "10.1186/1471-2407-14-70",
      "author": "LM Pradella",
      "doi-asserted-by": "publisher",
      "first-page": "70",
      "journal-title": "Cancer",
      "key": "11_CR13",
      "unstructured": "Pradella LM, Evangelisti C, Ligorio C et al (2014) A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer. Bmc. Cancer 14:70. doi:\n10.1186/1471-2407-14-70",
      "volume": "14",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s10549-014-2902-1",
      "author": "P Moller",
      "doi-asserted-by": "publisher",
      "first-page": "607",
      "issue": "3",
      "journal-title": "Breast Cancer Res Treat",
      "key": "11_CR14",
      "unstructured": "Moller P, Stormorken A, Holmen MM, Hagen AI, Vabo A, Maehle L (2014) The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation. Breast Cancer Res Treat 144(3):607–614. doi:\n10.1007/s10549-014-2902-1",
      "volume": "144",
      "year": "2014"
    },
    {
      "DOI": "10.1093/jnci/djt095",
      "author": "N Mavaddat",
      "doi-asserted-by": "publisher",
      "first-page": "812",
      "issue": "11",
      "journal-title": "J Natl Cancer Inst",
      "key": "11_CR15",
      "unstructured": "Mavaddat N, Peock S, Frost D et al (2013) Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst 105(11):812–822. doi:\n10.1093/jnci/djt095",
      "volume": "105",
      "year": "2013"
    },
    {
      "DOI": "10.1158/0008-5472.Can-05-4247",
      "author": "CC Wu",
      "doi-asserted-by": "publisher",
      "first-page": "8287",
      "issue": "16",
      "journal-title": "Cancer Res",
      "key": "11_CR16",
      "unstructured": "Wu CC, Shete S, Amos CI, Strong LC (2006) Joint effects of germ-line p53 mutation and sex on cancer risk in Li-Fraumeni syndrome. Cancer Res 66(16):8287–8292. doi:\n10.1158/0008-5472.Can-05-4247",
      "volume": "66",
      "year": "2006"
    },
    {
      "DOI": "10.1053/gast.2001.29611",
      "author": "PDP Pharoah",
      "doi-asserted-by": "publisher",
      "first-page": "1348",
      "issue": "6",
      "journal-title": "Gastroenterology",
      "key": "11_CR17",
      "unstructured": "Pharoah PDP, Guilford P, Caldas C, Consortiu IGCL (2001) Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 121(6):1348–1353. doi:\n10.1053/gast.2001.29611",
      "volume": "121",
      "year": "2001"
    },
    {
      "DOI": "10.1158/1078-0432.Ccr-06-0083",
      "author": "N Hearle",
      "doi-asserted-by": "publisher",
      "first-page": "3209",
      "issue": "10",
      "journal-title": "Clin Cancer Res",
      "key": "11_CR18",
      "unstructured": "Hearle N, Schumacher V, Menko FH et al (2006) Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 12(10):3209–3215. doi:\n10.1158/1078-0432.Ccr-06-0083",
      "volume": "12",
      "year": "2006"
    },
    {
      "DOI": "10.1136/jmedgenet-2012-101339",
      "author": "V Bubien",
      "doi-asserted-by": "publisher",
      "first-page": "255",
      "issue": "4",
      "journal-title": "J Med Genet",
      "key": "11_CR19",
      "unstructured": "Bubien V, Bonnet F, Brouste V et al (2013) High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome. J Med Genet 50(4):255–263. doi:\n10.1136/jmedgenet-2012-101339",
      "volume": "50",
      "year": "2013"
    },
    {
      "DOI": "10.1186/1897-4287-4-4-177",
      "author": "CF Rustad",
      "doi-asserted-by": "publisher",
      "first-page": "177",
      "issue": "4",
      "journal-title": "Hered Cancer Clin Pract",
      "key": "11_CR20",
      "unstructured": "Rustad CF, Bjornslett M, Heimdal KR, Maehle L, Apold J, Moller P (2006) Germline PTEN mutations are rare and highly penetrant. Hered Cancer Clin Pract 4(4):177–185. doi:\n10.1186/1897-4287-4-4-177",
      "volume": "4",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.cancergen.2015.06.001",
      "author": "F Aloraifi",
      "doi-asserted-by": "publisher",
      "first-page": "455",
      "issue": "9",
      "journal-title": "Cancer Genet",
      "key": "11_CR21",
      "unstructured": "Aloraifi F, McCartan D, McDevitt T, Green AJ, Bracken A, Geraghty J (2015) Protein-truncating variants in moderate-risk breast cancer susceptibility genes: a meta-analysis of high-risk case-control screening studies. Cancer Genet 208(9):455–463. doi:\n10.1016/j.cancergen.2015.06.001",
      "volume": "208",
      "year": "2015"
    },
    {
      "DOI": "10.1056/NEJMoa1400382",
      "author": "AC Antoniou",
      "doi-asserted-by": "publisher",
      "first-page": "497",
      "issue": "6",
      "journal-title": "N Engl J Med",
      "key": "11_CR22",
      "unstructured": "Antoniou AC, Casadei S, Heikkinen T et al (2014) Breast-cancer risk in families with mutations in PALB2. N Engl J Med 371(6):497–506. doi:\n10.1056/NEJMoa1400382",
      "volume": "371",
      "year": "2014"
    },
    {
      "DOI": "10.1097/GIM.0b013e3181ac9aea",
      "author": "JA Hobert",
      "doi-asserted-by": "publisher",
      "first-page": "687",
      "issue": "10",
      "journal-title": "Genet Med",
      "key": "11_CR23",
      "unstructured": "Hobert JA, Eng C (2009) PTEN hamartoma tumor syndrome: an overview. Genet Med 11(10):687–694. doi:\n10.1097/GIM.0b013e3181ac9aea",
      "volume": "11",
      "year": "2009"
    },
    {
      "DOI": "10.6004/jnccn.2010.0043",
      "author": "MB Daly",
      "doi-asserted-by": "crossref",
      "first-page": "562",
      "issue": "5",
      "journal-title": "J Natl Compr Canc Netw",
      "key": "11_CR24",
      "unstructured": "Daly MB, Axilbund JE, Buys S et al (2010) Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw 8(5):562–594",
      "volume": "8",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.ajhg.2010.11.013",
      "author": "MH Tan",
      "doi-asserted-by": "publisher",
      "first-page": "42",
      "issue": "1",
      "journal-title": "Am J Hum Genet",
      "key": "11_CR25",
      "unstructured": "Tan MH, Mester J, Peterson C et al (2011) A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands. Am J Hum Genet 88(1):42–56. doi:\n10.1016/j.ajhg.2010.11.013",
      "volume": "88",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s10549-015-3665-z",
      "author": "J Ngeow",
      "doi-asserted-by": "publisher",
      "journal-title": "Breast Cancer Res Treat",
      "key": "11_CR26",
      "unstructured": "Ngeow J, Sesock K, Eng C (2015) Breast cancer risk and clinical implications for germline PTEN mutation carriers. Breast Cancer Res Treat. doi:\n10.1007/s10549-015-3665-z",
      "year": "2015"
    },
    {
      "DOI": "10.1002/jso.23735",
      "author": "J Mester",
      "doi-asserted-by": "publisher",
      "first-page": "125",
      "issue": "1",
      "journal-title": "J Surg Oncol",
      "key": "11_CR27",
      "unstructured": "Mester J, Eng C (2015) Cowden syndrome: recognizing and managing a not-so-rare hereditary cancer syndrome. J Surg Oncol 111(1):125–130. doi:\n10.1002/jso.23735",
      "volume": "111",
      "year": "2015"
    },
    {
      "author": "JM Birch",
      "first-page": "1298",
      "issue": "5",
      "journal-title": "Cancer Res",
      "key": "11_CR28",
      "unstructured": "Birch JM, Hartley AL, Tricker KJ et al (1994) Prevalence and diversity of constitutional mutations in the P53 Gene among 21 Li-Fraumeni families. Cancer Res 54(5):1298–1304",
      "volume": "54",
      "year": "1994"
    },
    {
      "DOI": "10.1126/science.1978757",
      "author": "D Malkin",
      "doi-asserted-by": "crossref",
      "first-page": "1233",
      "issue": "4985",
      "journal-title": "Science",
      "key": "11_CR29",
      "unstructured": "Malkin D, Li FP, Strong LC et al (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250(4985):1233–1238",
      "volume": "250",
      "year": "1990"
    },
    {
      "DOI": "10.1038/348747a0",
      "author": "S Srivastava",
      "doi-asserted-by": "publisher",
      "first-page": "747",
      "issue": "6303",
      "journal-title": "Nature",
      "key": "11_CR30",
      "unstructured": "Srivastava S, Zou ZQ, Pirollo K, Blattner W, Chang EH (1990) Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348(6303):747–749. doi:\n10.1038/348747a0",
      "volume": "348",
      "year": "1990"
    },
    {
      "DOI": "10.1002/humu.10185",
      "author": "JM Varley",
      "doi-asserted-by": "publisher",
      "first-page": "313",
      "issue": "3",
      "journal-title": "Hum Mutat",
      "key": "11_CR31",
      "unstructured": "Varley JM (2003) Germline TP53 mutations and Li-Fraumeni syndrome. Hum Mutat 21(3):313–320. doi:\n10.1002/humu.10185",
      "volume": "21",
      "year": "2003"
    },
    {
      "DOI": "10.1002/humu.10081",
      "author": "M Olivier",
      "doi-asserted-by": "publisher",
      "first-page": "607",
      "issue": "6",
      "journal-title": "Hum Mutat",
      "key": "11_CR32",
      "unstructured": "Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P (2002) The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 19(6):607–614. doi:\n10.1002/humu.10081",
      "volume": "19",
      "year": "2002"
    },
    {
      "DOI": "10.1109/Ifita.2009.119",
      "author": "L Li",
      "doi-asserted-by": "publisher",
      "first-page": "453",
      "journal-title": "Int Forum Info Technol Appl Proc 2009",
      "key": "11_CR33",
      "unstructured": "Li L, Chen HC, Liu LX (2009) Sequence alignment algorithm in similarity measurement. Int Forum Info Technol Appl Proc 2009 1:453–456 doi:\n10.1109/Ifita.2009.119",
      "volume": "1",
      "year": "2009"
    },
    {
      "DOI": "10.1101/gr.107524.110",
      "author": "A McKenna",
      "doi-asserted-by": "publisher",
      "first-page": "1297",
      "issue": "9",
      "journal-title": "Genome Res",
      "key": "11_CR34",
      "unstructured": "McKenna A, Hanna M, Banks E et al (2010) The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20(9):1297–1303. doi:\n10.1101/gr.107524.110",
      "volume": "20",
      "year": "2010"
    },
    {
      "DOI": "10.1093/nar/gkq603",
      "author": "K Wang",
      "doi-asserted-by": "publisher",
      "first-page": "e164",
      "issue": "16",
      "journal-title": "Nucl Acids Res",
      "key": "11_CR35",
      "unstructured": "Wang K, Li M, Hakonarson H (2010) ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucl Acids Res 38(16):e164. doi:\n10.1093/nar/gkq603",
      "volume": "38",
      "year": "2010"
    },
    {
      "DOI": "10.1093/nar/29.1.308",
      "author": "ST Sherry",
      "doi-asserted-by": "crossref",
      "first-page": "308",
      "issue": "1",
      "journal-title": "Nucl Acids Res",
      "key": "11_CR36",
      "unstructured": "Sherry ST, Ward MH, Kholodov M et al (2001) dbSNP: the NCBI database of genetic variation. Nucl Acids Res 29(1):308–311",
      "volume": "29",
      "year": "2001"
    },
    {
      "DOI": "10.1038/nature15393",
      "author": "A Auton",
      "doi-asserted-by": "publisher",
      "first-page": "68",
      "issue": "7571",
      "journal-title": "Nature",
      "key": "11_CR37",
      "unstructured": "Genomes Project C, Auton A, Brooks LD et al (2015) A global reference for human genetic variation. Nature 526(7571):68–74. doi:\n10.1038/nature15393",
      "volume": "526",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nature19057",
      "author": "M Lek",
      "doi-asserted-by": "publisher",
      "first-page": "285",
      "issue": "7616",
      "journal-title": "Nature",
      "key": "11_CR38",
      "unstructured": "Lek M, Karczewski KJ, Minikel EV et al (2016) Analysis of protein-coding genetic variation in 60,706 humans. Nature 536(7616):285–291. doi:\n10.1038/nature19057",
      "volume": "536",
      "year": "2016"
    },
    {
      "DOI": "10.1093/nar/gkt1113",
      "author": "MJ Landrum",
      "doi-asserted-by": "publisher",
      "first-page": "D980",
      "issue": "D1",
      "journal-title": "Nucl Acids Res",
      "key": "11_CR39",
      "unstructured": "Landrum MJ, Lee JM, Riley GR et al (2014) ClinVar: public archive of relationships among sequence variation and human phenotype. Nucl Acids Res 42(D1):D980–D985. doi:\n10.1093/nar/gkt1113",
      "volume": "42",
      "year": "2014"
    },
    {
      "DOI": "10.1093/nar/gkh131",
      "author": "R Apweiler",
      "doi-asserted-by": "publisher",
      "first-page": "D115",
      "journal-title": "Nucl Acids Res",
      "key": "11_CR40",
      "unstructured": "Apweiler R, Bairoch A, Wu CH et al (2004) UniProt: the Universal Protein knowledgebase. Nucl Acids Res 32:D115–D119. doi:\n10.1093/nar/gkh131",
      "volume": "32",
      "year": "2004"
    },
    {
      "DOI": "10.1093/nar/gkt1223",
      "author": "RD Finn",
      "doi-asserted-by": "publisher",
      "first-page": "D222",
      "issue": "D1",
      "journal-title": "Nucl Acids Res",
      "key": "11_CR41",
      "unstructured": "Finn RD, Bateman A, Clements J et al (2014) Pfam: the protein families database. Nucl Acids Res 42(D1):D222–D230. doi:\n10.1093/nar/gkt1223",
      "volume": "42",
      "year": "2014"
    },
    {
      "DOI": "10.1002/(SICI)1098-1004(200001)15:1\u003c7::AID-HUMU4\u003e3.0.CO;2-N",
      "author": "JT den Dunnen",
      "doi-asserted-by": "crossref",
      "first-page": "7",
      "issue": "1",
      "journal-title": "Hum Mutat",
      "key": "11_CR42",
      "unstructured": "den Dunnen JT, Antonarakis SE (2000) Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion. Hum Mutat 15(1):7–12",
      "volume": "15",
      "year": "2000"
    },
    {
      "DOI": "10.1038/ng.2854",
      "author": "BA Thompson",
      "doi-asserted-by": "publisher",
      "first-page": "107",
      "issue": "2",
      "journal-title": "Nat Genet",
      "key": "11_CR43",
      "unstructured": "Thompson BA, Spurdle AB, Plazzer JP et al (2014) Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database. Nat Genet 46(2):107–115. doi:\n10.1038/ng.2854",
      "volume": "46",
      "year": "2014"
    },
    {
      "DOI": "10.1002/humu.22101",
      "author": "C Houdayer",
      "doi-asserted-by": "publisher",
      "first-page": "1228",
      "issue": "8",
      "journal-title": "Hum Mutat",
      "key": "11_CR44",
      "unstructured": "Houdayer C, Caux-Moncoutier V, Krieger S et al (2012) Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants. Hum Mutat 33(8):1228–1238. doi:\n10.1002/humu.22101",
      "volume": "33",
      "year": "2012"
    },
    {
      "DOI": "10.1002/humu.22428",
      "author": "D Di Giacomo",
      "doi-asserted-by": "publisher",
      "first-page": "1547",
      "issue": "11",
      "journal-title": "Hum Mutat",
      "key": "11_CR45",
      "unstructured": "Di Giacomo D, Gaildrat P, Abuli A et al (2013) Functional analysis of a large set of BRCA2 exon 7 variants highlights the predictive value of hexamer scores in detecting alterations of exonic splicing regulatory elements. Hum Mutat 34(11):1547–1557. doi:\n10.1002/humu.22428",
      "volume": "34",
      "year": "2013"
    },
    {
      "DOI": "10.1186/s12977-015-0154-8",
      "author": "S Erkelenz",
      "doi-asserted-by": "publisher",
      "first-page": "29",
      "journal-title": "Retrovirology",
      "key": "11_CR46",
      "unstructured": "Erkelenz S, Hillebrand F, Widera M et al (2015) Balanced splicing at the Tat-specific HIV-1 3’ss A3 is critical for HIV-1 replication. Retrovirology 12:29. doi:\n10.1186/s12977-015-0154-8",
      "volume": "12",
      "year": "2015"
    },
    {
      "DOI": "10.1126/science.1254806",
      "author": "HY Xiong",
      "doi-asserted-by": "publisher",
      "first-page": "1254806",
      "issue": "6218",
      "journal-title": "Science",
      "key": "11_CR47",
      "unstructured": "Xiong HY, Alipanahi B, Lee LJ et al (2015) The human splicing code reveals new insights into the genetic determinants of disease. Science 347(6218):1254806. doi:\n10.1126/science.1254806",
      "volume": "347",
      "year": "2015"
    },
    {
      "DOI": "10.1371/journal.pgen.1005756",
      "author": "O Soukarieh",
      "doi-asserted-by": "publisher",
      "first-page": "e1005756",
      "issue": "1",
      "journal-title": "PLoS Genet",
      "key": "11_CR48",
      "unstructured": "Soukarieh O, Gaildrat P, Hamieh M et al (2016) Exonic splicing mutations are more prevalent than currently estimated and can be predicted by using in silico tools. PLoS Genet 12(1):e1005756. doi:\n10.1371/journal.pgen.1005756",
      "volume": "12",
      "year": "2016"
    },
    {
      "DOI": "10.1136/jmg.2005.033878",
      "author": "SV Tavtigian",
      "doi-asserted-by": "publisher",
      "first-page": "295",
      "issue": "4",
      "journal-title": "J Med Genet",
      "key": "11_CR49",
      "unstructured": "Tavtigian SV, Deffenbaugh AM, Yin L et al (2006) Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Genet 43(4):295–305. doi:\n10.1136/jmg.2005.033878",
      "volume": "43",
      "year": "2006"
    },
    {
      "DOI": "10.1038/nprot.2009.86",
      "author": "P Kumar",
      "doi-asserted-by": "publisher",
      "first-page": "1073",
      "issue": "7",
      "journal-title": "Nat Protoc",
      "key": "11_CR50",
      "unstructured": "Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4(7):1073–1082. doi:\n10.1038/nprot.2009.86",
      "volume": "4",
      "year": "2009"
    },
    {
      "DOI": "10.1101/gr.3804205",
      "author": "EA Stone",
      "doi-asserted-by": "publisher",
      "first-page": "978",
      "issue": "7",
      "journal-title": "Genome Res",
      "key": "11_CR51",
      "unstructured": "Stone EA, Sidow A (2005) Physicochemical constraint violation by missense substitutions mediates impairment of protein function and disease severity. Genome Res 15(7):978–986. doi:\n10.1101/gr.3804205",
      "volume": "15",
      "year": "2005"
    },
    {
      "DOI": "10.1038/nmeth0410-248",
      "author": "IA Adzhubei",
      "doi-asserted-by": "publisher",
      "first-page": "248",
      "issue": "4",
      "journal-title": "Nat Methods",
      "key": "11_CR52",
      "unstructured": "Adzhubei IA, Schmidt S, Peshkin L et al (2010) A method and server for predicting damaging missense mutations. Nat Methods 7(4):248–249. doi:\n10.1038/nmeth0410-248",
      "volume": "7",
      "year": "2010"
    },
    {
      "DOI": "10.1038/nmeth.2890",
      "author": "JM Schwarz",
      "doi-asserted-by": "publisher",
      "first-page": "361",
      "issue": "4",
      "journal-title": "Nat Methods",
      "key": "11_CR53",
      "unstructured": "Schwarz JM, Cooper DN, Schuelke M, Seelow D (2014) MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 11(4):361–362. doi:\n10.1038/nmeth.2890",
      "volume": "11",
      "year": "2014"
    },
    {
      "DOI": "10.1007/978-1-60761-759-4$415",
      "author": "P Gaildrat",
      "doi-asserted-by": "publisher",
      "first-page": "249",
      "journal-title": "Methods Mol Biol",
      "key": "11_CR54",
      "unstructured": "Gaildrat P, Killian A, Martins A, Tournier I, Frebourg T, Tosi M (2010) Use of splicing reporter minigene assay to evaluate the effect on splicing of unclassified genetic variants. Methods Mol Biol 653:249–257. doi:\n10.1007/978-1-60761-759-4$415",
      "volume": "653",
      "year": "2010"
    },
    {
      "DOI": "10.1093/nar/gkv1222",
      "author": "MJ Landrum",
      "doi-asserted-by": "publisher",
      "first-page": "D862",
      "issue": "D1",
      "journal-title": "Nucl Acids Res",
      "key": "11_CR55",
      "unstructured": "Landrum MJ, Lee JM, Benson M et al (2016) ClinVar: public archive of interpretations of clinically relevant variants. Nucl Acids Res 44(D1):D862–D868. doi:\n10.1093/nar/gkv1222",
      "volume": "44",
      "year": "2016"
    },
    {
      "DOI": "10.1038/gim.2016.190",
      "author": "SS Kalia",
      "doi-asserted-by": "publisher",
      "first-page": "249",
      "issue": "2",
      "journal-title": "Genet Med",
      "key": "11_CR56",
      "unstructured": "Kalia SS, Adelman K, Bale SJ et al (2017) Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med 19(2):249–255. doi:\n10.1038/gim.2016.190",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1136/jmg.37.11.828",
      "author": "C Eng",
      "doi-asserted-by": "crossref",
      "first-page": "828",
      "issue": "11",
      "journal-title": "J Med Genet",
      "key": "11_CR57",
      "unstructured": "Eng C (2000) Will the real Cowden syndrome please stand up: revised diagnostic criteria. J Med Genet 37(11):828–830",
      "volume": "37",
      "year": "2000"
    },
    {
      "DOI": "10.1200/Jco.2014.60.3456",
      "author": "J Ngeow",
      "doi-asserted-by": "publisher",
      "first-page": "2537",
      "issue": "23",
      "journal-title": "J Clin Oncol",
      "key": "11_CR58",
      "unstructured": "Ngeow J, Liu C, Zhou K, Frick KD, Matchar DB, Eng C (2015) Detecting germline PTEN mutations among at-risk patients with cancer: an age- and sex-specific cost-effectiveness analysis. J Clin Oncol 33(23):2537–2581. doi:\n10.1200/Jco.2014.60.3456",
      "volume": "33",
      "year": "2015"
    },
    {
      "DOI": "10.1371/journal.pmed.1002230",
      "author": "A Hamblin",
      "doi-asserted-by": "publisher",
      "first-page": "e1002230",
      "issue": "2",
      "journal-title": "PLoS Med",
      "key": "11_CR59",
      "unstructured": "Hamblin A, Wordsworth S, Fermont JM et al (2017) Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: retrospective validation and prospective audit in the UK National Health Service. PLoS Med 14(2):e1002230. doi:\n10.1371/journal.pmed.1002230",
      "volume": "14",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s10549-016-3948-z",
      "author": "P Pinto",
      "doi-asserted-by": "publisher",
      "first-page": "245",
      "issue": "2",
      "journal-title": "Breast Cancer Res Treat",
      "key": "11_CR60",
      "unstructured": "Pinto P, Paulo P, Santos C et al (2016) Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity. Breast Cancer Res Treat 159(2):245–256. doi:\n10.1007/s10549-016-3948-z",
      "volume": "159",
      "year": "2016"
    },
    {
      "DOI": "10.1200/jco.2015.33.28_suppl.23",
      "doi-asserted-by": "crossref",
      "key": "11_CR61",
      "unstructured": "Yadav S, Fulbright J, Dreyfuss H et al (2015) Outcomes of retesting BRCA-negative patients using multigene panels. J Clin Oncol 33(Suppl 28):23"
    },
    {
      "DOI": "10.1200/JCO.2016.71.0012",
      "author": "MB Yurgelun",
      "doi-asserted-by": "publisher",
      "journal-title": "J Clin Oncol",
      "key": "11_CR62",
      "unstructured": "Yurgelun MB, Kulke MH, Fuchs CS et al (2017) Cancer susceptibility gene mutations in individuals with colorectal cancer. J Clin Oncol. doi:\n10.1200/JCO.2016.71.0012",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.jmoldx.2015.04.009",
      "author": "SE Lincoln",
      "doi-asserted-by": "publisher",
      "first-page": "533",
      "issue": "5",
      "journal-title": "J Mol Diagn",
      "key": "11_CR63",
      "unstructured": "Lincoln SE, Kobayashi Y, Anderson MJ et al (2015) A systematic comparison of traditional and multigene panel testing for hereditary breast and ovarian cancer genes in more than 1000 patients. J Mol Diagn 17(5):533–544. doi:\n10.1016/j.jmoldx.2015.04.009",
      "volume": "17",
      "year": "2015"
    },
    {
      "author": "AC Antoniou",
      "first-page": "1651",
      "issue": "17",
      "journal-title": "New Engl J Med",
      "key": "11_CR64",
      "unstructured": "Antoniou AC, Foulkes WD, Tischkowitz M (2014) Breast-cancer risk in families with mutations in PALB2 reply. New Engl J Med 371(17):1651–1652",
      "volume": "371",
      "year": "2014"
    },
    {
      "DOI": "10.2217/fon.12.34",
      "author": "AC Krepischi",
      "doi-asserted-by": "publisher",
      "first-page": "441",
      "issue": "4",
      "journal-title": "Future Oncol",
      "key": "11_CR65",
      "unstructured": "Krepischi AC, Pearson PL, Rosenberg C (2012) Germline copy number variations and cancer predisposition. Future Oncol 8(4):441–450. doi:\n10.2217/fon.12.34",
      "volume": "8",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s00109-017-1507-7",
      "author": "RA Villacis",
      "doi-asserted-by": "publisher",
      "journal-title": "J Mol Med",
      "key": "11_CR66",
      "unstructured": "Villacis RA, Basso TR, Canto LM et al (2017) Rare germline alterations in cancer-related genes associated with the risk of multiple primary tumor development. J Mol Med. doi:\n10.1007/s00109-017-1507-7",
      "year": "2017"
    },
    {
      "DOI": "10.1002/ijc.29948",
      "author": "RA Villacis",
      "doi-asserted-by": "publisher",
      "first-page": "1928",
      "issue": "8",
      "journal-title": "Int J Cancer",
      "key": "11_CR67",
      "unstructured": "Villacis RA, Miranda PM, Gomy I et al (2016) Contribution of rare germline copy number variations and common susceptibility loci in Lynch syndrome patients negative for mutations in the mismatch repair genes. Int J Cancer 138(8):1928–1935. doi:\n10.1002/ijc.29948",
      "volume": "138",
      "year": "2016"
    },
    {
      "DOI": "10.1182/blood-2009-10-201848",
      "author": "C O’Keefe",
      "doi-asserted-by": "publisher",
      "first-page": "2731",
      "issue": "14",
      "journal-title": "Blood",
      "key": "11_CR68",
      "unstructured": "O’Keefe C, McDevitt MA, Maciejewski JP (2010) Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies. Blood 115(14):2731–2739. doi:\n10.1182/blood-2009-10-201848",
      "volume": "115",
      "year": "2010"
    }
  ],
  "reference-count": 68,
  "references-count": 68,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-017-0011-0"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Potentially pathogenic germline CHEK2 c.319+2T\u0026gt;A among multiple early-onset cancer families"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "17"
}